SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-20-000108
Filing Date
2020-10-13
Accepted
2020-10-13 08:44:02
Documents
18
Period of Report
2020-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-20201011.htm   iXBRL 8-K 50097
2 EX-2.1 exhibit21vineyard-spae.htm EX-2.1 1018758
3 EX-99.1 vernalis8-kexhibit991p.htm EX-99.1 17175
9 image011.jpg GRAPHIC 8359
10 image01.jpg GRAPHIC 7411
  Complete submission text file 0000886163-20-000108.txt   1391844

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20201011.xsd EX-101.SCH 2430
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20201011_cal.xml EX-101.CAL 718
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20201011_def.xml EX-101.DEF 1655
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20201011_lab.xml EX-101.LAB 24270
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20201011_pre.xml EX-101.PRE 12654
11 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20201011_htm.xml XML 10786
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 201234756
SIC: 2834 Pharmaceutical Preparations